EE05532B1 - Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks - Google Patents

Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks

Info

Publication number
EE05532B1
EE05532B1 EEP200800065A EEP200800065A EE05532B1 EE 05532 B1 EE05532 B1 EE 05532B1 EE P200800065 A EEP200800065 A EE P200800065A EE P200800065 A EEP200800065 A EE P200800065A EE 05532 B1 EE05532 B1 EE 05532B1
Authority
EE
Estonia
Prior art keywords
preventing
pharmaceutical composition
composition containing
treating prostate
prostate enlargement
Prior art date
Application number
EEP200800065A
Other languages
English (en)
Inventor
Young Yu Jae
Min Choi Seul
Koo Kang Kyung
Ok Ahn Byoung
Yoo Moohi
Original Assignee
Dong-A Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong-A Pharmaceutical Co., Ltd. filed Critical Dong-A Pharmaceutical Co., Ltd.
Publication of EE200800065A publication Critical patent/EE200800065A/et
Publication of EE05532B1 publication Critical patent/EE05532B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200800065A 2006-04-04 2006-04-04 Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks EE05532B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2006/001242 WO2007114534A1 (en) 2006-04-04 2006-04-04 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound

Publications (2)

Publication Number Publication Date
EE200800065A EE200800065A (et) 2008-12-15
EE05532B1 true EE05532B1 (et) 2012-04-16

Family

ID=38563793

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200800065A EE05532B1 (et) 2006-04-04 2006-04-04 Pürasolopürimidinoonühendit sisaldav farmatseutiline kompositsioon eesnäärme- suurenemuse ärahoidmiseks ja raviks

Country Status (10)

Country Link
US (1) US8148386B2 (et)
JP (1) JP4975805B2 (et)
AU (1) AU2006341342B2 (et)
BR (1) BRPI0621588A2 (et)
CA (1) CA2647932C (et)
EE (1) EE05532B1 (et)
IL (1) IL194463A (et)
MX (1) MX2008012549A (et)
NZ (1) NZ571673A (et)
WO (1) WO2007114534A1 (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194529A1 (en) * 2007-02-12 2008-08-14 Auspex Pharmaceuticals, Inc. HIGHLY SELECTIVE and LONG-ACTING PDE5 MODULATORS
PE20130398A1 (es) 2010-07-15 2013-04-10 Oleg Iliich Epshtein Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo
ITTO20110631A1 (it) * 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizione farmaceutica di combinazione e metodi per trattare patologie del sistema genitourinario
RU2758373C2 (ru) * 2017-05-22 2021-10-28 Топадур Фарма Аг Новые активаторы растворимой гуанилатциклазы и ингибиторы фосфодиэстеразы с двойным механизмом действия и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9823102D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
WO2003066061A1 (en) * 2002-02-07 2003-08-14 Pfizer Limited Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome

Also Published As

Publication number Publication date
US20090099357A1 (en) 2009-04-16
IL194463A (en) 2014-11-30
JP4975805B2 (ja) 2012-07-11
JP2009532463A (ja) 2009-09-10
EE200800065A (et) 2008-12-15
MX2008012549A (es) 2009-01-14
IL194463A0 (en) 2009-08-03
NZ571673A (en) 2011-08-26
US8148386B2 (en) 2012-04-03
CA2647932A1 (en) 2007-10-11
WO2007114534A1 (en) 2007-10-11
CA2647932C (en) 2011-06-07
BRPI0621588A2 (pt) 2011-12-13
AU2006341342B2 (en) 2010-05-20
AU2006341342A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
BRPI0610514A2 (pt) composto, composição farmacêutica, e, método de tratamento de um distúrbio
BRPI0809977A2 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
DK1986650T3 (da) Manipulationssikre doserignsformer
DK2384754T3 (da) Farmaceutiske doseringsformer
ZA200808530B (en) Pharmaceutical composition for external use
ZA200808531B (en) Pharmaceutical composition for external use
HK1121162A1 (en) Oxazole compound and pharmaceutical composition
BRPI0819232A2 (pt) composto heterocíclico e composição farmacêutica do mesmo
ATE509842T1 (de) Dosenende für eine dose und solch eine dose
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
EP2057987A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN ENCAPSULATED STATINE NANOPARTICLE
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0607748A2 (pt) composto, composição farmacêutica, e, método de tratamento de um distúrbio
EP1971354A4 (en) LIQUIRITIGENIN-BASED COMPOSITION FOR THE PREVENTION AND TREATMENT OF HEPATIC DISEASES
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0810399A2 (pt) Composto, composição farmacêutica que o contém e uso do mesmo
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
BRPI0914182A2 (pt) composto, e, composição farmacêutica
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0912074A2 (pt) composto e composição farmacêutica